ZNF217 and breast carcinoma: Indeed, in vitro overexpression of ZNF217 promoted cell proliferation in ovarian [27] and breast cancer cells [28], whereas silencing of ZNF217 reduced it in prostate [23], colorectal [21], ovarian [7, 29] and breast [28] cancer cells.